CLINICAL_TRIALS
research
· 2026-03-19
Clinical Trial Update: IASO-782 in Systemic Lupus Erythematosus [Phase 1]
Summary
A Phase 1 clinical trial evaluating IASO-782 for systemic lupus erythematosus is not yet recruiting, according to the trial record.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai IASO Biotechnology Co., Ltd | Conditions: SLE - Systemic Lupus Erythematosus | Phase 1 | Status: NOT_YET_RECRUITING